Study Finds Lower Conception Rates Among Women Who Got mRNA COVID Shots
A recent large-scale population study conducted in the Czech Republic and published this month in the International Journal of Risk & Safety in Medicine has found that women who received a COVID-19 biologic prior to conception were significantly less likely to achieve a successful pregnancy compared to their unvaccinated peers. According to authors of the […]
Study Calls for Genetic Screening Before Infants Get Vaccinated
A new peer-reviewed study published in the International Journal of Medical Sciences suggests that genetic differences in how infants metabolize vaccine ingredients may play a critical and previously underrecognized role in sudden infant death syndrome (SIDS)—the unexplained death of an apparently healthy infant under one year old. The authors of the study, published on Apr. […]
Novel “Inverse Vaccines” Could Soon Target Autoimmune Diseases
A novel class of therapies that are labeled vaccines—known as ‘inverse vaccines’—are designed to treat autoimmune disorders and could be made available in just a few years. In January, Swiss biotech company Anokion—which focuses on improving treatments and health outcomes for individuals suffering with autoimmune disorders—announced promising early human trials of inverse “vaccines” targeting celiac […]
Cardiac Deaths Have Increased 17 Percent in Years Following the COVID-19 Pandemic
A new population-based study conducted by researchers at Harvard-affiliated Mass General Brigham has found that cardiac deaths have increased significantly since the onset of the COVID-19 pandemic, with many occurring in homes rather than hospitals. Published May 30, 2025 in JAMA Network Open, the study offers one of the most comprehensive analyses to date examining […]
Clinical Trials Now Required for Annual COVID Shots Given to Healthy Adults
On May 20, 2025, the U.S. Food and Drug Administration (FDA) announced that new clinical trials will be required to approve annual COVID-19 booster shots for healthy adults under age 65. In a joint editorial published in the New England Journal of Medicine, FDA commissioner Marty Makary, MD and the director of the FDA’s Center […]
FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants
The U.S. Food and Drug Administration (FDA) has licensed Sanofi’ SA’s four-valent MenQuadfi meningococcal vaccine for use in infants aged six weeks to 23 months old to prevent invasive meningococcal disease. Previously approved for children aged two and older, MenQuadfi is now the first meningococcal vaccine included on the U.S. Centers for Disease Control and […]